0480-4490

Generic: tasimelteon

Labeler: teva pharmaceuticals, inc.
NDC Directory DRUG FOR FURTHER PROCESSING DRUG FOR FURTHER PROCESSING Active

Drug Facts

Product Profile

Brand Name
Generic Name tasimelteon
Labeler teva pharmaceuticals, inc.
Dosage Form CAPSULE, GELATIN COATED
Active Ingredients

tasimelteon 20 mg/1

Identifiers & Regulatory

Product NDC 0480-4490
Product ID 0480-4490_066cf6d6-da45-451d-ad2b-3b6203e2c10c
Product Type DRUG FOR FURTHER PROCESSING
Marketing Category DRUG FOR FURTHER PROCESSING
Listing Expiration 2026-12-31
Marketing Start 2023-05-30

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 04804490
Hyphenated Format 0480-4490

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name tasimelteon (source: label)
Generic Name tasimelteon (source: ndc)
Application Number ANDA211601 (source: label)
Routes
oral
source: label

Resolved Composition

Strengths
  • 20 mg/1
source: ndc
Packaging
  • 19950 CAPSULE, GELATIN COATED in 1 BOX (0480-4490-00)
source: ndc

Packages (1)

Ingredients (1)

tasimelteon (20 mg/1)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"spl_id": "066cf6d6-da45-451d-ad2b-3b6203e2c10c", "openfda": {}, "finished": false, "packaging": [{"description": "19950 CAPSULE, GELATIN COATED in 1 BOX (0480-4490-00)", "package_ndc": "0480-4490-00", "marketing_start_date": "30-MAY-23"}], "product_id": "0480-4490_066cf6d6-da45-451d-ad2b-3b6203e2c10c", "dosage_form": "CAPSULE, GELATIN COATED", "product_ndc": "0480-4490", "generic_name": "Tasimelteon", "labeler_name": "Teva Pharmaceuticals, Inc.", "product_type": "DRUG FOR FURTHER PROCESSING", "brand_name_base": null, "active_ingredients": [{"name": "TASIMELTEON", "strength": "20 mg/1"}], "marketing_category": "DRUG FOR FURTHER PROCESSING", "marketing_start_date": "20230530", "listing_expiration_date": "20261231"}